BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Panczyk M. Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years. World J Gastroenterol 2014; 20(29): 9775-9827 [PMID: 25110414 DOI: 10.3748/wjg.v20.i29.9775]
URL: https://www.wjgnet.com/1007-9327/full/v20/i29/9775.htm
Number Citing Articles
1
Lisa A. Varughese, Kelsey S. Lau‐Min, Christine Cambareri, Nevena Damjanov, Ryan Massa, Nandi Reddy, Randall Oyer, Ursina Teitelbaum, Sony Tuteja. DPYDandUGT1A1Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical ImplementationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2020; 40(11): 1108 doi: 10.1002/phar.2463
2
Anastasios Ntavatzikos, Aris Spathis, Paul Patapis, Nikolaos Machairas, George Peros, Stefanos Konstantoudakis, Danai Leventakou, Ioannis G Panayiotides, Petros Karakitsos, Anna Koumarianou. Integrating <i>TYMS</i>, <i>KRAS</i> and <i>BRAF</i> testing in patients with metastatic colorectal cancerWorld Journal of Gastroenterology 2017; 23(32): 5913-5924 doi: 10.3748/wjg.v23.i32.5913
3
Vânia Diogo, Joana Teixeira, Patrícia M.A. Silva, Hassan Bousbaa. Spindle Assembly Checkpoint as a Potential Target in Colorectal Cancer: Current Status and Future PerspectivesClinical Colorectal Cancer 2017; 16(1): 1 doi: 10.1016/j.clcc.2016.06.006
4
Raffaele Palmirotta, Claudia Carella, Erica Silvestris, Mauro Cives, Stefania Luigia Stucci, Marco Tucci, Domenica Lovero, Franco Silvestris. SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksandOncotarget 2018; 9(38): 25355 doi: 10.18632/oncotarget.25256
5
Amirreza Hesari, Amir Maleksabet, Abolfazl Nosrati Tirkani, Hamideh Ghazizadeh, Elmira Iranifar, Fatoalah Mohagheg, Ali Arash Anoshrvani, Faezeh Ghasemi. Evaluation of the two polymorphisms rs1801133 in MTHFR and rs10811661 in CDKN2A/B in breast cancerJournal of Cellular Biochemistry 2019; 120(2): 2090 doi: 10.1002/jcb.27517
6
Sona Vodenkova, Tomas Buchler, Klara Cervena, Veronika Veskrnova, Pavel Vodicka, Veronika Vymetalkova. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and futurePharmacology & Therapeutics 2020; 206: 107447 doi: 10.1016/j.pharmthera.2019.107447
7
Jie Chai, Wei Dong, Chao Xie, Lin Wang, Da-Li Han, Shan Wang, Hong-Liang Guo, Zong-Li Zhang. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYDIUBMB Life 2015; 67(3): 191 doi: 10.1002/iub.1361
8
Peilong Li, Xin Zhang, Lili Wang, Lutao Du, Yongmei Yang, Tong Liu, Chen Li, Chuanxin Wang. lncRNA HOTAIR Contributes to 5FU Resistance through Suppressing miR-218 and Activating NF-κB/TS Signaling in Colorectal CancerMolecular Therapy - Nucleic Acids 2017; 8: 356 doi: 10.1016/j.omtn.2017.07.007
9
João Crispim Encarnação, Ana Salomé Pires, Renata Alexandra Amaral, Telmo José Gonçalves, Mafalda Laranjo, João Eduardo Casalta-Lopes, Ana Cristina Gonçalves, Ana Bela Sarmento-Ribeiro, Ana Margarida Abrantes, Maria Filomena Botelho. Butyrate, a dietary fiber derivative that improves irinotecan effect in colon cancer cellsThe Journal of Nutritional Biochemistry 2018; 56: 183 doi: 10.1016/j.jnutbio.2018.02.018
10
Yinghui Zhao, Chuanxin Wang, Ajay Goel. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancerCarcinogenesis 2021; 42(6): 814 doi: 10.1093/carcin/bgab027
11
Dongdong Luo, Yuhang Zhang, Shuang Yang, Xiaochen Tian, Yan Lv, Zhikun Guo, Xiaochun Liu, Gaitian Han, Shuai Liu, Wenyu Wang, Shuxiang Cui, Xianjun Qu, Shengbiao Wan. Design, synthesis and biological evaluation of sphingosine-1-phosphate receptor 2 antagonists as potent 5-FU-resistance reversal agents for the treatment of colorectal cancerEuropean Journal of Medicinal Chemistry 2021; 225: 113775 doi: 10.1016/j.ejmech.2021.113775
12
Xin-Xin Wang, Peng-cheng Yu, Jun Li. High-Throughput Metabolomics for Identification of Metabolic Pathways and Deciphering the Effect Mechanism of Dioscin on Rectal Cancer From Cell Metabolic Profiles Coupled With Chemometrics AnalysisFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00068
13
Shen-Jeu Won, Ting-Yu Lin, Cheng-Hsin Yen, Yu-Hau Tzeng, Hsiao-Sheng Liu, Chun-Nan Lin, Cheng-Hao Yu, Chi-Shiuan Wu, Jyun-Ti Chen, Yi-Ting Chen, Chi-Ying F. Huang, Chun-Li Su. A novel natural tautomeric pair of garcinielliptone FC suppressed nuclear factor κB and induced apoptosis in human colorectal cancer cellsJournal of Functional Foods 2016; 24: 568 doi: 10.1016/j.jff.2016.05.003
14
Ghada Al Bayyat, Dan Arreaza-Kaufman, Nandini Venkateswaran, Anat Galor, Carol L. Karp. Update on pharmacotherapy for ocular surface squamous neoplasiaEye and Vision 2019; 6(1) doi: 10.1186/s40662-019-0150-5
15
Karolina Tecza, Jolanta Pamula-Pilat, Joanna Lanuszewska, Dorota Butkiewicz, Ewa Grzybowska. Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patientsOncotarget 2018; 9(10): 9114 doi: 10.18632/oncotarget.24148
16
Hwani Ryu, Ky-Youb Nam, Hyo Jeong Kim, Jie-Young Song, Sang-Gu Hwang, Jae Sung Kim, Joon Kim, Jiyeon Ahn. Discovery of a Novel Triazolopyridine Derivative as a Tankyrase InhibitorInternational Journal of Molecular Sciences 2021; 22(14): 7330 doi: 10.3390/ijms22147330
17
Hiroyuki Fujikawa, Yuji Toiyama, Yasuhiro Inoue, Yusuke Omura, Shozo Ide, Takahito Kitajima, Hiromi Yasuda, Yoshinaga Okugawa, Yoshiki Okita, Shigeyuki Yoshiyama, Junichiro Hiro, Minako Kobayashi, Masaki Ohi, Toshimitsu Araki, Masato Kusunoki. Phase�I study of preoperative chemoradiotherapy with sequential oxaliplatin and irinotecan with S‑1 for locally advanced rectal cancerOncology Letters 2019;  doi: 10.3892/ol.2019.10028
18
Ziyu Li, Xiaofang Xing, Fei Shan, Shuangxi Li, Zhongwu Li, Aitang Xiao, Zhaodong Xing, Kan Xue, Zhemin Li, Ying Hu, Yongning Jia, Rulin Miao, Lianhai Zhang, Zhaode Bu, Aiwen Wu, Jiafu Ji. ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patientsOncotarget 2016; 7(34): 55449 doi: 10.18632/oncotarget.10961
19
Linrong Pang, Jinger Lu, Jia Huang, Caihong Xu, Hui Li, Guangbo Yuan, Xiaochun Cheng, Jun Chen. Upregulation of miR‑146a increases cisplatin sensitivity of the non‑small cell lung cancer A549 cell line by targeting JNK‑2Oncology Letters 2017;  doi: 10.3892/ol.2017.7242
20
Erika Cecchin, Elena De Mattia, Fabrizio Ecca, Giuseppe Toffoli. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementationDrug Resistance Updates 2018; 39: 18 doi: 10.1016/j.drup.2018.07.001
21
Inna Zubrilov, Orit Sagi-Assif, Sivan Izraely, Tsipi Meshel, Shlomit Ben-Menahem, Ravit Ginat, Metsada Pasmanik-Chor, Clara Nahmias, Pierre-Olivier Couraud, Dave S.B. Hoon, Isaac P. Witz. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cellsCancer Letters 2015; 361(1): 86 doi: 10.1016/j.canlet.2015.02.041
22
Abdurakhim Toychiev, Sulayman Abdujapparov, Alim Imamov, Behzod Navruzov, Nikolay Davis, Najiya Badalova, Svetlana Osipova. Intestinal helminths and protozoan infections in patients with colorectal cancer: prevalence and possible association with cancer pathogenesisParasitology Research 2018; 117(12): 3715 doi: 10.1007/s00436-018-6070-9
23
Zeynep N. Erdem, Stefanie Schwarz, Daniel Drev, Christine Heinzle, Andrea Reti, Petra Heffeter, Xenia Hudec, Klaus Holzmann, Bettina Grasl-Kraupp, Walter Berger, Michael Grusch, Brigitte Marian. Irinotecan Upregulates Fibroblast Growth Factor Receptor 3 Expression in Colorectal Cancer Cells, Which Mitigates Irinotecan-Induced ApoptosisTranslational Oncology 2017; 10(3): 332 doi: 10.1016/j.tranon.2017.02.004
24
Wenjun Hu, Linping Lei, Xuqin Xie, Libin Huang, Qian Cui, Tang Dang, Gang Logan Liu, Yuan Li, Xiaofeng Sun, Zongguang Zhou. Heterogeneous nuclear ribonucleoprotein L facilitates recruitment of 53BP1 and BRCA1 at the DNA break sites induced by oxaliplatin in colorectal cancerCell Death & Disease 2019; 10(8) doi: 10.1038/s41419-019-1784-x
25
Francis Yew Fu Tieng, Rashidah Baharudin, Nadiah Abu, Ryia-Illani Mohd Yunos, Learn-Han Lee, Nurul-Syakima Ab Mutalib. Single Cell Transcriptome in Colorectal Cancer—Current Updates on Its Application in Metastasis, Chemoresistance and the Roles of Circulating Tumor CellsFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00135
26
RWK Wu, CMN Yow, Eric Law, ESM Chu, Zheng Huang. Effect of Foslip® mediated photodynamic therapy on 5-fluorouracil resistant human colorectal cancer cellsPhotodiagnosis and Photodynamic Therapy 2020; 31: 101945 doi: 10.1016/j.pdpdt.2020.101945
27
Ko-Chao Lee, Chien-Tsong Lin, Shun-Fu Chang, Cheng-Nan Chen, Jing-Lan Liu, Wen-Shih Huang. Effect of AICAR and 5-Fluorouracil on X-ray Repair, Cross-Complementing Group 1 Expression, and Consequent Cytotoxicity Regulation in Human HCT-116 Colorectal Cancer CellsInternational Journal of Molecular Sciences 2017; 18(11): 2363 doi: 10.3390/ijms18112363
28
Mahshid Mohammadian, Shima Zeynali-Moghaddam, Mohammad Hassan Khadem Ansari, Yousef Rasmi, Anahita Fathi Azarbayjani, Fatemeh Kheradmand. Dihydropyrimidine Dehydrogenase Levels in Colorectal Cancer Cells Treated with a Combination of Heat Shock Protein 90 Inhibitor and Oxaliplatin or CapecitabineAdvanced Pharmaceutical Bulletin 2019; 9(3): 439 doi: 10.15171/apb.2019.052
29
Ane Sørlie Kværner, Jun Minaguchi, Naouale El Yamani, Christine Henriksen, Hanna Ræder, Ingvild Paur, Hege Berg Henriksen, Gro Wiedswang, Sigbjørn Smeland, Rune Blomhoff, Andrew Richard Collins, Siv Kjølsrud Bøhn. DNA damage in blood cells in relation to chemotherapy and nutritional status in colorectal cancer patients—A pilot studyDNA Repair 2018; 63: 16 doi: 10.1016/j.dnarep.2018.01.005
30
Guoying Jin, Yuhang Liu, Jia Zhang, Zehua Bian, Surui Yao, Bojian Fei, Leyuan Zhou, Yuan Yin, Zhaohui Huang. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancerCancer Chemotherapy and Pharmacology 2019; 84(2): 315 doi: 10.1007/s00280-019-03867-6
31
Wensong Yao, Zhen Lin, Peiying Shi, Bing Chen, Gang Wang, Jianyong Huang, Yuxia Sui, Qicai Liu, Shaoguang Li, Xinhua Lin, Qicai Liu, Hong Yao. Delicaflavone induces ROS-mediated apoptosis and inhibits PI3K/AKT/mTOR and Ras/MEK/Erk signaling pathways in colorectal cancer cellsBiochemical Pharmacology 2020; 171: 113680 doi: 10.1016/j.bcp.2019.113680
32
Goretti Duran, Raquel Cruz, Ana Rita Simoes, Francisco Barros, José María Giráldez, Beatriz Bernárdez, Urbano Anido, Sonia Candamio, Rafael López-López, Ángel Carracedo, María Jesús Lamas. Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics?Journal of Chemotherapy 2020; 32(6): 310 doi: 10.1080/1120009X.2020.1764281
33
Joske Ubels, Tilman Schaefers, Cornelis Punt, Henk-Jan Guchelaar, Jeroen de Ridder. RAINFOREST: a random forest approach to predict treatment benefit in data from (failed) clinical drug trialsBioinformatics 2020; 36(Supplement_2): i601 doi: 10.1093/bioinformatics/btaa799
34
Jorge Hernando-Cubero, Ignacio Matos-García, Vicente Alonso-Orduña, Jaume Capdevila. The Role of Fluoropirimidines in Gastrointestinal Tumours: from the Bench to the BedJournal of Gastrointestinal Cancer 2017; 48(2): 135 doi: 10.1007/s12029-017-9946-5
35
Sujit Nair, Ah-Ng Tony Kong. Architecture of Signature miRNA Regulatory Networks in Cancer ChemopreventionCurrent Pharmacology Reports 2015; 1(2): 89 doi: 10.1007/s40495-014-0014-6
36
Yongfeng Guo, Bing Han, Kongliang Luo, Zhijian Ren, Lei Cai, Li Sun. NOX2-ROS-HIF-1α signaling is critical for the inhibitory effect of oleanolic acid on rectal cancer cell proliferationBiomedicine & Pharmacotherapy 2017; 85: 733 doi: 10.1016/j.biopha.2016.11.091
37
Zehua Bian, Yuyang Feng, Yao Xue, Yaling Hu, Qifeng Wang, Leyuan Zhou, Zhihui Liu, Jiwei Zhang, Yuan Yin, Bing Gu, Zhaohui Huang. Down-regulation of SNX1 predicts poor prognosis and contributes to drug resistance in colorectal cancerTumor Biology 2016; 37(5): 6619 doi: 10.1007/s13277-015-3814-3
38
Ki Heon Choi, Joohee Jung. Anti-proliferation Effect of Coscinoderma sp. Extract on Human Colon Cancer CellsJournal of Food Hygiene and Safety 2016; 31(4): 294 doi: 10.13103/JFHS.2016.31.4.294
39
Amirsaeed Sabeti Aghabozorgi, Mostafa Moradi Sarabi, Reza Jafarzadeh-Esfehani, Shabnaz Koochakkhani, Marziyeh Hassanzadeh, Soudabeh Kavousipour, Ebrahim Eftekhar. Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acidsWorld Journal of Gastrointestinal Oncology 2020; 12(9): 942-956 doi: 10.4251/wjgo.v12.i9.942
40
William A. Hammond, Abhisek Swaika, Kabir Mody. Pharmacologic resistance in colorectal cancer: a reviewTherapeutic Advances in Medical Oncology 2016; 8(1): 57 doi: 10.1177/1758834015614530
41
Isaac Micallef, Byron Baron. The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal CancerNon-Coding RNA 2021; 7(2): 24 doi: 10.3390/ncrna7020024
42
MIKA HOSOKAWA, MAI SAITO, AIKO NAKANO, SAKURA IWASHITA, AYANO ISHIZAKA, KUMIKO UEDA, SEIGO IWAKAWA. Acquired resistance to decitabine and cross-resistance to gemcitabine during the long-term treatment of human HCT116 colorectal cancer cells with decitabineOncology Letters 2015; 10(2): 761 doi: 10.3892/ol.2015.3253
43
Heather F. Sinner, Jeremy Johnson, Piotr G. Rychahou, David S. Watt, Yekaterina Y. Zaytseva, Chunming Liu, B. Mark Evers, Javier S Castresana. Novel chemotherapeutic agent, FND-4b, activates AMPK and inhibits colorectal cancer cell proliferationPLOS ONE 2019; 14(10): e0224253 doi: 10.1371/journal.pone.0224253
44
Ayat B. Al-Ghafari, Khadijah S. Balamash, Huda A. Al Doghaither. Relationship between Serum Vitamin D and Calcium Levels and Vitamin D Receptor Gene Polymorphisms in Colorectal CancerBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/8571541
45
Wei Wu, Ke He, Qian Guo, Jingdi Chen, Mengjiao Zhang, Kai Huang, Dongmei Yang, Lu Wu, Yunchao Deng, Xu Luo, Honggang Yu, Qianshan Ding, Guoan Xiang. SSRP1 promotes colorectal cancer progression and is negatively regulated by miR‐28‐5pJournal of Cellular and Molecular Medicine 2019; 23(5): 3118 doi: 10.1111/jcmm.14134
46
David I. Cantor, Harish R. Cheruku, Jack Westacott, Joo-Shik Shin, Abidali Mohamedali, Seong Boem Ahn. Proteomic investigations into resistance in colorectal cancerExpert Review of Proteomics 2020; 17(1): 49 doi: 10.1080/14789450.2020.1713103
47
Lei Zhu, Jianfeng Cao, Guochuang Chen, Yanghui Xu, Jingbo Lu, Fang Fang, Kaoshan Chen. Anti-tumor and immunomodulatory activities of an exopolysaccharide from Rhizopus nigricans on CT26 tumor-bearing miceInternational Immunopharmacology 2016; 36: 218 doi: 10.1016/j.intimp.2016.04.033
48
Jonathan Escalante, Rachel M. McQuade, Vanesa Stojanovska, Kulmira Nurgali. Impact of chemotherapy on gastrointestinal functions and the enteric nervous systemMaturitas 2017; 105: 23 doi: 10.1016/j.maturitas.2017.04.021
49
Jie Dou, Zhou Wang, Leon Ma, Bo Peng, Ke Mao, Chengqin Li, Mengqi Su, Changlin Zhou, Guangyong Peng. Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescenceOncotarget 2018; 9(28): 20089 doi: 10.18632/oncotarget.24015
50
Yanping Guan, Yuanyuan Fu, Yao Liu, Siyi Wang, Man Zhao, Zhongming Jin, Fulin Jiang, Liang Hong, Min Huang, Min Li, Guoping Zhong. Quantitative bioanalytical LC–MS/MS assay for S130 in rat plasma-application to a pharmacokinetic studyBioanalysis 2019; 11(16): 1469 doi: 10.4155/bio-2019-0101
51
Chunhong Zhang, Yangjie Xu, Haowen Wang, Gang Li, Han Yan, Zhenghua Fei, Yunsheng Xu, Wenfeng Li. Curcumin reverses irinotecan resistance in colon cancer cell by regulation of epithelial–mesenchymal transitionAnti-Cancer Drugs 2018; 29(4): 334 doi: 10.1097/CAD.0000000000000599
52
Si-Qi Zhang, Kui-Jie Liu, Hong-Liang Yao, San-Lin Lei, Zhen-Dong Lei, Wen-Jun Yi, Li Xiong, Hua Zhao. Photodynamic therapy as salvage therapy for residual microscopic cancer after ultra-low anterior resection: A case reportWorld Journal of Clinical Cases 2019; 7(6): 798-804 doi: 10.12998/wjcc.v7.i6.798
53
Prashanth Gokare, Niklas K. Finnberg, Phillip H. Abbosh, Jenny Dai, Maureen E. Murphy, Wafik S. El-Deiry. P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targetingScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09859-x
54
Gui-wei Liu, Yan-hua Liu, Guo-sheng Jiang, Wei-dan Ren. The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanismHuman Cell 2018; 31(3): 189 doi: 10.1007/s13577-017-0189-3
55
Ya Wang, Qunhui Wei, Yuqiao Chen, Shichao Long, Yuanbing Yao, Kai Fu. Identification of Hub Genes Associated With Sensitivity of 5-Fluorouracil Based Chemotherapy for Colorectal Cancer by Integrated Bioinformatics AnalysisFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.604315
56
Kha Wai Hon, Nadiah Abu, Nurul-Syakima Ab Mutalib, Rahman Jamal. miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal CancerFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00846
57
Yan-Yan Zhu, Qiong Jin, Shan-Shan Chen, Dan-Ni Jin, Zhao-Jie Wang, Ying-Jie He, Hui-Cheng Chen, Yun-Li Zhao, Li-Xing Zhao, Zhi Dai, Xiao-Dong Luo. Neothalfine, a potent natural anti-tumor agent against metastatic colorectal cancer and its primary mechanismBioorganic & Medicinal Chemistry 2021; 29: 115849 doi: 10.1016/j.bmc.2020.115849
58
Meng-Die Yang, Wen-Jun Zhou, Xiao-Le Chen, Jian Chen, Qing Ji, Qi Li, Wen-Hai Wang, Shi-Bing Su. Therapeutic Effect and Mechanism of Bushen-Jianpi-Jiedu Decoction Combined with Chemotherapeutic Drugs on Postoperative Colorectal CancerFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.524663
59
Yong Yang, Guoxin Wang, Dajian Zhu, Yanfeng Huang, Yong Luo, Pengfei Su, Xiaowu Chen, Qian Wang. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancerInternational Journal of Oncology 2017; 51(2): 515 doi: 10.3892/ijo.2017.4044
60
Seyung S. Chung, Pranabananda Dutta, David Austin, Piwen Wang, Adam Awad, Jaydutt V. Vadgama. Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cellsOncotarget 2018; 9(68): 32943 doi: 10.18632/oncotarget.25993
61
Feng Wang, Xianfei Ding, Tao Wang, Zhengzheng Shan, Jun Wang, Shaoxuan Wu, Yanyan Chi, Yana Zhang, Zhuan Lv, Liuxing Wang, Qingxia Fan, Aamir Ahmad. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatinPLOS ONE 2017; 12(4): e0174276 doi: 10.1371/journal.pone.0174276
62
Xin Xie, Yu Zhao, Chun-Yan Ma, Xiao-Ming Xu, Yan-Qiu Zhang, Chen-Guang Wang, Jing Jin, Xin Shen, Jin-Lai Gao, Na Li, Zhi-Jie Sun, De-Li Dong. Dimethyl fumarate induces necroptosis in colon cancer cells through GSH depletion/ROS increase/MAPKs activation pathwayBritish Journal of Pharmacology 2015; 172(15): 3929 doi: 10.1111/bph.13184
63
Jun Zou, Weihua Kuang, Jilong Hu, Huamin Rao. miR-216b promotes cell growth and enhances chemosensitivity of colorectal cancer by suppressing PDZ-binding kinaseBiochemical and Biophysical Research Communications 2017; 488(2): 247 doi: 10.1016/j.bbrc.2017.03.162
64
Miguel Cordova-Delgado, María Loreto Bravo, Elisa Cumsille, Charlotte N. Hill, Matías Muñoz-Medel, Mauricio P. Pinto, Ignacio N. Retamal, María A. Lavanderos, Juan Francisco Miquel, Maria Rodriguez-Fernandez, Yuwei Liao, Zhiguang Li, Alejandro H. Corvalán, Ricardo Armisén, Marcelo Garrido, Luis A. Quiñones, Gareth I. Owen. A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancerBMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08745-0
65
Lin-Lin Cao, Hangqi Liu, Zhihong Yue, Lianhua Liu, Lin Pei, Junxu Gu, Hui Wang, Mei Jia. Iron chelation inhibits cancer cell growth and modulates global histone methylation status in colorectal cancerBioMetals 2018; 31(5): 797 doi: 10.1007/s10534-018-0123-5
66
Qiang Wang, Yan-long Shi, Kai Zhou, Li-li Wang, Ze-xuan Yan, Yu-lin Liu, Li-li Xu, Shi-wei Zhao, Hui-li Chu, Ting-ting Shi, Qing-hua Ma, Jingwang Bi. PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancerCell Death & Disease 2018; 9(7) doi: 10.1038/s41419-018-0776-6
67
J.A. Willis, E. Vilar. Pharmacogenomics: time to rethink its role in precision medicineAnnals of Oncology 2018; 29(2): 293 doi: 10.1093/annonc/mdx780
68
Guolin Zhang, Xin Luo, Wei Zhang, Engeng Chen, Jianbin Xu, Fei Wang, Gaoyang Cao, Zhenyu Ju, Dongai Jin, Xuefeng Huang, Wei Zhou, Zhangfa Song. CXCL-13 Regulates Resistance to 5-Fluorouracil in Colorectal CancerCancer Research and Treatment 2020; 52(2): 622 doi: 10.4143/crt.2019.593
69
Yi Zheng, Qin Ouyang, Ruoqiu Fu, Lei Liu, Hongwei Zhang, Xiaoye Hu, Yanxia Liu, Yingchun Chen, Ning Gao. The cyclohexene derivative MC-3129 exhibits antileukemic activity via RhoA/ROCK1/PTEN/PI3K/Akt pathway-mediated mitochondrial translocation of cofilinCell Death & Disease 2018; 9(6) doi: 10.1038/s41419-018-0689-4
70
Hanane Akhdar, Said El Shamieh, Orlando Musso, Romain Désert, Wissam Joumaa, Dominique Guyader, Caroline Aninat, Anne Corlu, Fabrice Morel, Matias A. Avila. The rs3957357C>T SNP in GSTA1 Is Associated with a Higher Risk of Occurrence of Hepatocellular Carcinoma in European IndividualsPLOS ONE 2016; 11(12): e0167543 doi: 10.1371/journal.pone.0167543
71
Aritro Nath, Jacqueline Wang, R. Stephanie Huang. Pharmacogenetics and Pharmacogenomics of Targeted Therapeutics in Chronic Myeloid LeukemiaMolecular Diagnosis & Therapy 2017; 21(6): 621 doi: 10.1007/s40291-017-0292-x
72
Sara Gagno, Michele Bartoletti, Chiara Romualdi, Elena Poletto, Simona Scalone, Roberto Sorio, Martina Zanchetta, Elena De Mattia, Rossana Roncato, Erika Cecchin, Giorgio Giorda, Giuseppe Toffoli. Pharmacogenetic score predicts overall survival, progression-free survival and platinum sensitivity in ovarian cancerPharmacogenomics 2020; 21(14): 995 doi: 10.2217/pgs-2020-0049
73
Jun Ma, Guangyi Gao, Hong Lu, Dong Fang, Lingchang Li, Guoli Wei, Aifei Chen, Yong Yang, Hongying Zhang, Jiege Huo. Reversal effect of ginsenoside Rh2 on oxaliplatin‑resistant colon cancer cells and its mechanismExperimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.7604
74
Xiaoli Zhang, Shuhua Shan, Hanqing Li, Jiangying Shi, Yang Lu, Zhuoyu Li. Cloning, expression of the truncation of recombinant peroxidase derived from millet bran and its reversal effects on 5-Fu resistance in colorectal cancerInternational Journal of Biological Macromolecules 2019; 132: 871 doi: 10.1016/j.ijbiomac.2019.03.111